Introduction
============

There is growing evidence indicating that patients with eating disorders (EDs) present difficulties expressing and regulating emotions ([@B24]). Increasing evidence supports preceding emotion regulation (ER) models ([@B40]; [@B27]) that postulate that ER difficulties often lead to the implementation of less appropriate strategies (e.g., maladaptive food intake or deliberate self-harm) to mollify unpleasant emotions. Likewise, deficits in ER observed among individuals suffering from EDs have been hypothesized to underlie the high prevalence of non-suicidal self-injury (NSSI) behaviors, which range from 21 to 59% in this clinical population ([@B37]; [@B9]; [@B32]; [@B11]). Still, among individuals with clinical EDs, those who engage in NSSI have higher dietary restrictions and higher rates of binging and/or purging symptomatology ([@B64]; [@B58]).

NSSI behaviors are described as deliberate self-induced harm actions on the surface of one's body that usually cause bleeding, bruising, or pain (e.g., cutting, burning, and hitting) without suicidal intention ([@B3]). Notably, similar ER difficulties have been postulated for EDs and NSSI behaviors; namely, both reveal difficulties in thinking, planning, or implementing adaptive coping strategies ([@B60]; [@B8]; [@B46]; [@B68]; [@B10]; [@B37]; [@B32]; [@B11]). Within this clinical population both maladaptive food intake and NSSI behaviors can be implemented as a maladaptive ER strategy that enables the individual to avoid, manage or lessen unpleasant emotions ([@B5]; [@B1]; [@B44]). In order to better explain this phenomenon, [@B5] proposed the Experiential Avoidance Model (EAM) of NSSI. According to the EAM, NSSI behaviors aim to reduce or eliminate unwanted emotional responses (mostly perceived physiological arousal) and thus, these behaviors are primarily maintained by negative reinforcement.

In physiological terms, emotions can be framed in a body--mind interaction model where both current body state (e.g., physiological arousal) and associated cognitions are coupled to embody the emotional state and subjective experience of the emotion, which in turn can lead to the resulting ER processes. A well-accepted way to assess autonomic nervous system state is through measuring the heart rate variability (HRV) index ([@B70]; [@B43]), a variation in the heart's beat-to-beat interval ([@B56]; [@B51]). It has been suggested that both higher and lower HRV are mainly determined by the parasympathetic system ([@B41]; [@B30]; [@B25]; [@B52]; [@B51]). EDs have been associated with alterations in the autonomic nervous system, however, results are still inconclusive with most studies accounting increased HRV to parasympathetic nervous system dominance, whereas others describe decreased HRV conveying dominance of the sympathetic nervous system, or no differences comparing HRV in ED patients to controls ([@B43]; [@B48],[@B49]). Additionally, HRV is an objective measure that has been considered as an index of ER capacity in a large number of studies ([@B15]; [@B66]; [@B67]; [@B69]). Specifically, it has been proposed that higher HRV is associated with a greater capacity to regulate negative emotions in terms of emotional clarity (i.e., the capacity to identify these emotions) and emotional impulse-control (to adaptively inhibit or regulate emotional responses). Likewise, lower HRV is associated with the ER difficulties observed in certain psychopathological vulnerabilities, such as trait anxiety (a relatively stable, temperamental predisposition to anxiety; [@B71]). Also, decreased HRV is observed in anxious states (i.e., transitory emotional state characterized by subjective feelings of attention, apprehension and autonomic nervous system hyperactivity), which are associated with increased physiological effects \[increased heart rate (HR)\], sweating and decreased HRV ([@B53]; [@B38]; [@B6]) and vagal deactivation. Although most studies measuring HRV are based on resting paradigms, some studies explore HRV as a biofeedback measure ([@B59]; [@B39]). To date, there are limited studies on the use of biofeedback in the treatment of ED ([@B45]; [@B16]). Still, it could be of interest to see how individuals differ in in-task HRV during biofeedback sessions.

Importantly, anxiety is highly linked to ER capacity ([@B31]; [@B26]; [@B54]) and it has been described as one of the main unpleasant emotions commonly experienced by NSSI patients. It is also one of the main factors associated with a greater likelihood of engaging in these behaviors ([@B20]; [@B57]; [@B72]). Specifically, [@B26] reported that higher trait anxiety was associated with negative ER strategies through stronger connections between the amygdala and dorsal anterior cingulate cortex (areas involved in emotional reactivity) and the inferior temporal gyrus and paracentral lobule (areas associated with perceptual and sensory processing). However, despite its relevant implications on the EDs and NSSI field, no studies have been conducted so far focusing on state/trait anxiety and HRV indices with in this population.

As such, the main aims of the present study were the following: (1) to compare state, trait anxiety and in-task HRV (measured through a serious videogame in a biofeedback task that triggers the implementation of ER strategies) in three different groups: ED with NSSI (ED+NSSI), ED without NSSI (ED-NSSI), and healthy controls (HC), and (2) to test state-trait anxiety and in-task HRV as independent predictors of NSSI in ED+NSSI patients in a cross-sectional study. In-task HRV indices were obtained while participants were engaged in the Playmancer ([@B17]) biofeedback videogame implemented to train the regulation of the elicited unpleasant emotions (e.g., anxiety, frustration). We hypothesize that: (1) ED+NSSI patients will present higher levels of state and trait anxiety than ED-NSSI patients, and that both groups will differ in these measures when compared with HC; (2) State-trait anxiety and in-task HRV will independently predict the presence of NSSI in ED+NSSI patients.

Materials and Methods {#s1}
=====================

Participants
------------

A total of 66 participants were included in this study: 22 HC, 32 ED-NSSI, and 12 ED+NSSI. The ED-NSSI group was 59% bulimia nervosa (BN, *n* = 19), 25% anorexia nervosa restrictive type (AN-R, *n* = 18), 12.5% anorexia nervosa binge-eating/purging type (AN-B/P, *n* = 4) and 3% of otherwise specified feeding or ED purging subtype (OSFED-P, *n* = 1). The ED+NSSI group was 50% BN (*n* = 6), 25% AN-R (*n* = 3), 17% binge ED (BED, *n* = 2) and 8% AN-B/P (*n* = 1). The prevalence of NSSI among the different ED diagnoses of our total sample was 100% in BED, 24% in BN, 20% in AN-B/P, 14% in AN-R and 0% in OSFED-P. The presence of ED were diagnosed by experienced psychologists and psychiatrists according to DSM-IV-TR criteria ([@B2]) by means of a semi-structured clinical interview adapted from the SCID-I ([@B19]). ED diagnoses were recoded *post hoc* according to DSM-5 diagnostic criteria ([@B3]). ED patients were consecutive referrals for assessment and treatment at the Psychiatry Department of the University Hospital of Bellvitge (Barcelona, Spain). Only women ranging from 18 to 60 years of age were included in the study sample. All patients were classified in two groups according to presence of lifetime history of NSSI behaviors or absence of lifetime history of NSSI behaviors. The HC group was made up of volunteer participants from our hospital staff and student interns. Exclusion criteria for the whole sample at intake were as follows: having a primary psychiatric or neurological disorder (psychotic disorder, bipolar disorder, major depressive disorder, substance abuse and/or dependence, or epilepsy), and/or receiving a pharmacological treatment that may interfere with the recording of physiological data. In the ED-NSSI group, patients could not have a history of NSSI behaviors. HC did not have a history of ED, NSSI behaviors, or any other psychopathological conditions.

This study was carried out in accordance with the recommendations of the Ethics Committee of the University Hospital of Bellvitge with written informed consent being obtained from all subjects in accordance with the Declaration of Helsinki.

Assessment
----------

### Evaluation of NSSI Behaviors and Other Clinical Variables

At the beginning of the study, a clinical interview was conducted to explore questions such as ED symptoms using the SCID-I ([@B19]) and the presence of associated impulsive behaviors (such as drug or alcohol abuse/dependence). Psychometric and anthropometric measures \[such as body mass index (BMI)\] were also taken. Similar to [@B32], the existence of current or lifetime regular NSSI behaviors was assessed by means of a clinical interview by experienced psychologist and psychiatrists. We considered NSSI behaviors to be self-cutting, burning, hitting, and scratching, not performed with a suicidal intent. Drug or alcohol abuse, bingeing and vomiting behaviors were not included as NSSI.

### Psychometric Measures

*Symptom Checklist revised* (*SCL-90-R*; [@B13], [@B14]): This 90-item questionnaire is widely used for the measurement of self-reported overall psychological distress and psychopathology. It is scored with the following dimensions: Somatization, Obsessive--Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism. A global severity index is used as a global distress index. The Spanish validation of this instrument has shown a mean internal consistency of α = 0.75 ([@B42]). Given that depression has been shown to influence the occurrence of NSSI ([@B20]; [@B57]; [@B72]), the depression subscale was used in this study as a covariate. All the subscales have good internal consistency in this study (α ranged from 0.822 to 0.982).

*State-Trait Anxiety Inventory* (*STAI-S-T*; [@B63]): This is a self-report questionnaire that includes 40 items. It consists of two subscales, each one made up of 20 items, that measure "state anxiety" and "trait anxiety." The Spanish adaptation ([@B62]) obtained good reliability indices in psychometric studies. Cronbach's alpha reliability is 0.90 for trait anxiety and 0.94 for state anxiety ([@B28]). In our sample, Cronbach's alpha reliability is 0.940 for trait anxiety and 0.961 for state anxiety.

*Eating Disorders Inventory-2* (*EDI-2*; [@B21]): This 91-item questionnaire assesses cognitive and behavioral characteristics that are common in ED. It contains eight scales (Drive for Thinness, Bulimia, Body Dissatisfaction, Ineffectiveness, Perfectionism, Interpersonal Distrust, Interoceptive Awareness, and Maturity Fears) and three provisional scales (Asceticism, Impulse Regulation, and Social Insecurity) answered on a 6-point Likert scale. In the present study, the EDI-2 total score, understood as a severity grade, was used in statistical analyses to compare each group's characteristics. It has been validated in a Spanish population ([@B22]) with a mean internal consistency of 0.63 (coefficient alpha). Cronbach's alpha reliability of the EDI-2 total scores of this sample is 0.958.

### Physiological Measure

The physiological variable employed in this study was in-task HRV. This measure was recorded while participants played a serious videogame named "Playmancer." Serious games are games designed for a specific purpose that goes beyond that of pure entertainment. They are applied with an explicit goal in contexts such as healthcare, with educational, preventive, and/or therapeutic purposes ([@B23]). As described in previous studies ([@B33]; [@B18]), our serious game is based on biofeedback techniques and is used as an additional therapeutic tool, combined with standard psychological treatment approaches for ED. The main goal of this intervention is to teach strategies to enhance self-control and to regulate negative emotions (e.g., anxiety and frustration) when the individual has to face different challenges. Playmancer treatment usually lasts 10 weeks with a session per week. The challenges are presented via three different activities (mini-games) that the player has to carry out: (1) *The Face of Cronos*: In this game, the player must reach the top of a cliff, trying to dodge different obstacles that appear during the climb according to the individual's arousal level (higher physiological activation leads to the appearance of more obstacles); (2) *Treasures of the Sea*: In this swimming game, the player must find different hidden treasures while trying to regulate their oxygen consumption. Higher physiological activation causes an increase in the oxygen consumption, making the task more difficult to complete; and (3) *Sign of the Magupta*: In this relaxation game, the player has to complete different constellations of stars via slow, deep breathing techniques.

As a part of our videogame system and for biofeedback purposes, electrocardiogram (ECG) sensors are placed to measure the participants' electrical heart activity. To do so, two skin electrodes are placed on the chest, as follows: one electrode (negative) is placed above the ninth-tenth rib, on the right side; the other electrode (positive) is also placed above the 9th to 10th rib, but on the left side. These sensors are the source for ECG lead, HR, and HRV. Thereby, from other biofeedback variables, this videogame program calculates the average HRV of the player during the session. HRV reflects the fluctuation in HR. In our videogame system, HRV is given as percentage relative to the average HR. If the last two beats found by the beat-to-beat algorithm are at times *T*~n-1~ and *T*~n~ (in seconds), then the momentary HR is (60/Δ*T*) where Δ*T* = *T*~n~ -*T*~n-1~. HRV is the difference between momentary and average HR, averaged over the last eight beats to reduce the impact of breathing (**Figure [1](#F1){ref-type="fig"}**). HRV was acquired through the TMSi Mobi8 amplifier sensor system. Sensors are connected via wires to the Mobi8. The Mobi8 receives measurement data from sensors and sends them via Bluetooth^TM^ to the Playmancer desktop PC application where data is recorded. Each recording session lasts 26 min. Higher HRV reflects less physiological activation, whereas lower HRV indicates more physiological activation and, thus, increased anxiety levels ([@B41]; [@B56]; [@B51]). For more information about this serious game, see [@B33] and [@B18].

![Hart rate variability (HRV) measurement formula.](fpsyg-08-01163-g001){#F1}

Procedure
---------

All participants with EDs (ED+NSSI and ED-NSSI) were assessed with a clinical interview and completed the aforementioned questionnaires, as part of the assessment and diagnostic protocol of our Unit. All anxiety measures were completed within the same day, including questionnaires and the ER biofeedback task (Playmancer serious videogame). HC participants followed the same procedure: they first completed the diagnostic protocol and self-reported questionnaires followed by the Playmancer task. Although Playmancer treatment lasts 10 sessions (see [@B17] for further description), in this study, we used the information from the first session, since we aimed to measure "baseline" in-task HRV from all participants, that is, when they have not yet modified any of their physiological patterns as a product of the ER training.

Statistical Analysis
--------------------

Statistical analysis was carried out with STATA13.1 for Windows. Firstly, analysis of variance (ANOVA) adjusted for the covariates SCL-90R depression score and ED subtype compared the means for clinical variables and anxiety dimensions between the three independent groups (HC, ED-NSSI, and ED+NSSI). Regarding using the SCL-90R depression subscale as a covariable, it was included since previous studies have described that depressive state is a powerful risk factor for the presence of NSSI ([@B20]); therefore, the inclusion of depressive symptom levels avoid the potential bias due to its confounding effects. The ANOVA analyses included pairwise comparisons through Bonferroni's method and estimated the mean difference size through Cohen's-*d* coefficient (\|*d*\| \> 0.50 was considered moderate and \|*d*\| \> 0.80 was considered high).

Secondly, Pearson's correlations described the relationships between the main variables of the study. The correlation matrix was stratified by diagnostic subtype (coefficients were separately estimated for the HC, ED-NSSI, and ED+NSSI subsamples) since the associations between the variables could be different depending on the diagnostic group. This correlation matrix was included with two main objectives: (a) to describe the pattern of relationships for the main variables of the study, and (b) to identify potential problems due to the presence of collinearity between variables that could affect the predictive logistic models.

Thirdly, a logistic regression assessed the predictive capacity of STAI scales (state and trait) and HRV for the presence of the NSSI behavior (0 = absent versus 1 = present) in the ED samples. This model was programmed in two blocks/steps: (a) the first block included and set the covariates: patient's age, BMI (since it has been reported that HRV is related to BMI; [@B35], [@B36]), SCL-90R depression and the ED subtype; and (b) the second block added anxiety and HRV measures. Goodness-of-fit was measured with the Hosmer--Lemeshow test (*p* \> 0.05 was considered adequate fitting), the global predictive capacity with the Nagelkerke's pseudo-*R*^2^ coefficient (the adjusted contribution of the predictors was calculated as the increase between blocks 1 and 2, Δ*R*^2^) and the global discriminative capacity with the area under the ROC curve (AUC).

Results
=======

Comparison of Clinical and Anxiety Measures between Groups
----------------------------------------------------------

**Table [1](#T1){ref-type="table"}** includes the results of the ANOVA (adjusted for SCL-90-R depression and ED subtype) comparing mean scores of clinical variables and anxiety dimensions between the three groups of the study, pairwise comparisons and effect size (Cohen's-d value). Participants' age, age of onset of the ED, duration of the ED, and BMI were equally distributed between groups, and only one mean difference in the moderate range was found: the pairwise comparison of the chronological age between the two ED groups (31.8 for ED-NSSI versus 26.8 for EDI+NSSI; *d* = 0.53). Considering anxiety measures, more relevant differences emerged. First, compared to both the ED-NSSI and ED+NSSI groups, HC registered lower mean scores in the STAI-state and STAI-trait scales, but no differences among groups were observed in in-task HRV indices. Second, ED+NSSI obtained higher means compared to the ED-NSSI group on the STAI-trait scale. ED severity (EDI-2 total score) significantly and clinically differed comparing HC with both ED subtypes, while differences between ED-NSSI and ED+NSSI patients were non-significant.

###### 

Comparison of clinical variables and anxiety dimensions between groups.

                                HC      ED-NSSI   ED+NSSI   Factor   Pairwise comparisons                                                                                                                
  ----------------------------- ------- --------- --------- -------- ---------------------- ------ ------ ------ -------------- -------------- ------------- -------------- ------------- -------------- -------------
  Age (year)                    28.55   7.88      31.77     9.70     26.83                  8.78   1.65   2/63   0.201          0.199          0.37          0.597          0.21          0.109          **0.53^†^**
  Age of onset (year)                             21.19     8.02     17.92                  8.30   1.43   1/32   0.239                                                                    0.239          0.40
  Duration ED (year)                              10.58     9.05     8.92                   6.35   0.34   1/32   0.562                                                                    0.562          0.21
  BMI (kg/m^2^)                 20.81   1.85      21.30     4.74     23.83                  9.48   1.06   2/63   0.353          0.800          0.14          0.200          0.44          0.195          0.34
  ^1^SCL-90R: depression        0.83    0.32      1.81      1.05     2.63                   0.89   5.25   2/63   **0.009^∗^**   **0.048^∗^**   **1.16**      **0.013^∗^**   **2.68**      **0.017^∗^**   **0.84^†^**
  ^1^ED severity: EDI-2 total   44.5    11.2      85.4      45.2     90.2                   41.1   9.05   2/63   **0.001^∗^**   **0.001^∗^**   **1.24^†^**   **0.002^∗^**   **1.52^†^**   0.636          0.11
  ^2^Heart rate variability     4.68    2.09      5.20      2.38     4.25                   1.64   0.75   2/63   0.479          0.749          0.23          0.794          0.24          0.229          0.46
  ^2^STAI: anxiety-state        20.61   10.31     28.35     8.85     31.46                  9.97   1.51   2/63   0.230          0.160          **0.81^†^**   0.088          **1.07^†^**   0.354          0.33
  ^3^STAI: anxiety-trait        18.79   6.95      33.89     9.08     39.43                  5.06   8.75   2/63   **0.001^∗^**   **0.001^∗^**   **1.87^†^**   **0.001^∗^**   **3.40^†^**   **0.039^∗^**   **0.75^†^**
                                                                                                                                                                                                         

SD, standard deviation; \|

d

\|, Cohen's-

d

measuring effect-size; Df, degrees of freedom. HC, healthy controls; ED-NSSI, eating disorders without non-suicidal self-injury; ED+NSSI, eating disorders with non-suicidal self-injury.

1

Adjusted for ED subtype.

2

Adjusted for age, BMI, SCL-90R depression score, and ED subtype.

3

Adjusted for SCL-90R depression score and ED subtype.

∗

Bold: significant comparison (0.05 level).

†

Bold: effect size in the moderate (\|

d

\| \> 0.50) to high range (\|

d

\| \> 0.80).

Correlations between the Main Variables of the Study
----------------------------------------------------

The Pearson's correlation-matrix for the main variables of the study, stratified by the diagnostic subtype, describes the pattern of associations in each group. In ED-NSSI patients: (a) the HRV index negatively correlated with the age (*r* = -0.345, *p* \< 0.05); (b) the state and trait anxiety scores positively correlated with ED severity (*r* = 0.323, *p* \< 0.05 and *r* = 0.540, *p* \< 0.001, consecutively), and with depression (*r* = 0.370, *p* \< 0.05 and *r* = 0.516, *p* \< 0.001); and (c) state and trait anxiety positively inter-correlated (*r* = 0.586, *p* \< 0.05). In the ED+NSSI group more associations and with a higher effect size emerged: (a) HRV index positively correlated with ED severity (*r* = 0.256, *p* \< 0.05); (b) and state anxiety correlated with age (*r* = 0.686, *p* \< 0.05), BMI (*r* = 0.469, *p* \< 0.05), ED severity (*r* = 0.310, *p* \< 0.05) and depression (*r* = 0.338, *p* \< 0.05); and (c) trait anxiety correlated with and ED severity (*r* = 0.267, *p* \< 0.05) and HRV (*r* = 0.385, *p* \< 0.05). Finally, in HC: (a) HRV index negatively correlated with age (*r* = -0.708, *p* \< 0.001) and positively with anxiety trait levels (*r* = 0.304, *p* \< 0.05); and (b) anxiety state correlated with depression levels (*r* = 0.315, *p* \< 0.05); and (c) anxiety state and trait levels positively correlated (*r* = 0.492, *p* \< 0.05).

This correlation matrix did not evidence the presence of very high correlations between variables that could affect the predictive models due to collinearity.

Predictive Model for the Presence of NSSI in the ED Groups
----------------------------------------------------------

**Table [2](#T2){ref-type="table"}** presents the results of the second block-step for the final logistic regression assessing the predictive capacity of anxiety (STAI scales) and in-task HRV indices for the presence of NSSI. Adjusted for the covariates patient's age, BMI, SCL-90-R depression and ED subtype, the risk of presenting NSSI was increased for ED patients with higher STAI-trait scores. STAI-state scale scores and in-task HRV indices did not statistically contribute to the outcome. This model achieved adequate fit (*p* = 0.875) and high predictive and discriminative capacity (*R*^2^ = 0.18, AUC = 0.84).

###### 

Logistic regression assessing the predictive capacity of anxiety and in-task HRV for the presence of NSSI in the ED sample.

                                                       *B*      SE      Wald    *p*            OR     95% CI   OR
  ---------------------------------------------------- -------- ------- ------- -------------- ------ -------- -------
  Constant                                             -8.208   4.072   4.062   0.044          0.00            
  Age (year)                                           -0.137   0.076   3.213   **0.030^∗^**   0.87   0.75     1.00
  BMI (kg/m^2^)                                        0.168    0.107   2.438   0.080          1.18   0.96     1.46
  SCL-90R depression (covariate)                       0.554    0.557   0.992   0.297          1.74   0.58     5.18
  ED subtype (covariate)                               1.418    1.306   1.179   0.261          4.13   0.32     53.33
  STAI: anxiety-trait                                  0.152    0.082   3.457   **0.044^∗^**   1.16   1.00     1.37
  STAI: anxiety-state                                  0.015    0.058   0.066   0.797          1.01   0.91     1.14
  HRV index                                            -0.249   0.253   0.969   0.303          0.78   0.48     1.28
  Fitting: H--L: 0.594; Δ*R*^2^ = 0.140; AUC = 0.891                                                           
                                                                                                               

ED, eating disorder; H--L, Hosmer--Lemeshow test; Δ

R

2

, increase in the Nagelkerke's

R

-square after adjusting for the covariate depression; AUC, area under ROC curve.

∗

Bold: significant comparison (0.05 level).

Discussion
==========

This study aimed to compare state/trait anxiety and in-task HRV indices (through a serious videogame in a biofeedback task that triggers the implementation of ER strategies) in three different samples: ED patients with NSSI, ED patients without NSSI and HC. We also sought to test state-trait anxiety and in-task HRV as independent predictors of NSSI in ED patients. Results show that ED patients have significantly higher trait anxiety scores and higher state anxiety scores with significant effect sizes, although without significant *p* values, than HC. Still, no significant differences are observed for the in-task HRV indices. Also and most importantly, results reveal that trait anxiety plays a pivotal role in the presence of NSSI behaviors among the ED patients.

Individuals with ED have been widely described as a population with poor ER skills ([@B29]; [@B65]; [@B4]; [@B12]) as well as with higher levels of state anxiety ([@B34]) and trait anxiety ([@B61]) when compared to HC. Our data adds additional evidence of the higher rates of anxiety among these individuals and stresses the need to target these symptoms for treatment purposes.

Additionally, NSSI behaviors are highly prevalent among patients with disordered eating ([@B37]; [@B9]; [@B32]; [@B11]) and both ER difficulties, as well as high anxiety scores, may account for this association ([@B60]; [@B46]; [@B68]). In line with these results, previous studies have also suggested that trait and state anxiety are triggering factors for NSSI behaviors ([@B57]; [@B72]), with trait anxiety described as a predisposing factor for the occurrence of NSSI ([@B20]; [@B55]). Based on this previous literature, we hypothesized that ED patients with NSSI behaviors would also present higher state-trait anxiety scores when compared to ED patients without NSSI behaviors. However, contrary to our hypothesis we did not find any differences in state anxiety between EDs with NSSI and EDs without NSSI. Instead, the results of this study suggest that the NSSI behaviors in EDs are more associated with higher trait anxiety. One explanation for this finding is that, in comparison with previous studies, our ED sample (with and without NSSI) may have presented similar levels of state anxiety mainly due to their shared ED condition. Nonetheless, these results need to be interpreted cautiously and further explored in future studies.

Additionally, our logistic regression model analysis demonstrated that trait anxiety was the only variable that predicts NSSI behaviors among the ED patients in our sample. Considering that individuals with NSSI often use these behaviors as a way to manage negative emotions ([@B5]; [@B1]; [@B44]), it stands to reason that those who usually feel anxious are more likely to commit NSSI. Thus, the general predisposition to feel anxious, rather than the state experience of anxiety, could be a main factor to consider in the study and for the development of therapeutic approaches for ED patients at risk of NSSI behaviors. From a clinical perspective, special attention should be paid to those patients with ED who present higher trait anxiety levels in order to provide ER interventions and help with the prevention of possible NSSI behaviors.

Finally, EDs have been associated with alterations in the autonomic nervous system ([@B43]; [@B48],[@B49]). In this regard, we found no significant in-task HRV differences when conducting the Playmancer-ER task. Although most previous studies have reported increased in-task HRV ([@B43]), our findings are in line with other studies reporting no differences in HRV reactivity in ED ([@B49]). Also, we explored in-task HRV differences between the ED with and without NSSI. The rational for exploring these differences through the Playmancer-ER task was to observe different physiological indices associated with the presence of NSSI behaviors, which are highly associated with ER difficulties. Previous studies have reported different physiological indices in NSSI compared to those who do not present NSSI ([@B47]), however, our results do not support these findings. The reported divergences could possibly be due to different methods for assessing HRV or to constrained sample sizes. Nevertheless, our results raise the necessity to further explore these variables in order to better understand alterations in the autonomic nervous system in ED patients.

To our knowledge, few studies on ED patients with NSSI have exclusively focused on the role of anxiety in itself. In this regard, our study is the first that explores which dimension of anxiety (state or trait) is associated with NSSI behaviors in individuals with ED, including not only subjective (self-reported questionnaires) but also objective (physiological) measurements. Thus, this research contributes to conceptualize NSSI in ED and raises many questions worthy of further investigation.

Nevertheless, the generalization of the reported results is subject to certain limitations. First, based on previous studies ([@B50]) and given that we were considering ED along continuum with ER problems and disordered eating, this study has not differentiated between different EDs. However, future studies should explore differences between disorders. Also, more studies are needed with larger samples and less sample size differences which also include males, before the obtained results can be generalized. Additionally, recall biases might also be a limiting factor inherent in retrospective and cross-sectional assessments. Thus future longitudinal studies are required to specifically determine the role of state and trait anxiety as predictors of NSSI in ED patients. With regards to the assessment techniques, Playmancer in-task HRV indices are adequate for measuring HRV indices through an ER task ([@B59]; [@B39]) but results may be linked to different emotions (e.g., anxiety, frustration) and this study does not provide extra manipulation check measures. Given that previous studies often use the classic baseline and recovery period HRV measures with stress or anxiety provoking tasks, our in-task HRV results, which are based on a biofeedback-ER task are still difficult to compare with the current literature. Moreover, we explored the presence of NSSI only through a clinical interview without including a psychometric assessment, which would have allowed us to obtain more detailed information about subjects' self-harm behaviors (e.g., frequency, intensity, etc.). We cannot omit the role that other factors such as impulsivity and compulsivity could also have in the occurrence of these NSSI behaviors ([@B7]). However, together with impulsivity and compulsivity, trait anxiety should also be considered in future studies in ED NSSI behaviors. Regarding depressive symptoms, it must be highlighted that this factor could also bias the results; though we did control for this variable to minimize its impact. Future studies could also target depressive symptoms and compare them with trait anxiety scores to see if these two factors equally predispose NSSI behaviors in ED patients. Finally, since this study was carried out with a low sample size for the comparisons between groups (statistical power was low), mean differences with significant (*p* \< 0.05) or moderate to high effect sizes (\|*d*\| \> 0.50) were considered as relevant in the work.

Conclusion
==========

In conclusion, our results suggest that trait anxiety plays a larger role than state anxiety in the occurrence of NSSI in patients with ED. Anxious temperament could be a main factor in choosing maladaptive strategies (i.e., NSSI behaviors) as a mechanism to regulate negative emotions. From a clinical perspective, these results uphold that special attention should be paid to those patients with ED who present high trait anxiety levels and that such patients should be provided with targeted ER interventions in order to prevent possible NSSI behaviors. Although the results of the present study are promising, further research through longitudinal studies is needed to corroborate these findings.
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